Claudia Bocca Selected Research

Claudia Bocca Research Topics

Disease

9	Breast Neoplasms (Breast Cancer) 02/2014 - 01/2004
8	Neoplasms (Cancer) 02/2022 - 01/2004
8	Hypoxia (Hypoxemia) 12/2019 - 10/2012
5	Colonic Neoplasms (Colon Cancer) 10/2012 - 08/2007
4	Carcinogenesis 12/2009 - 07/2007
3	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2017
3	Liver Neoplasms (Liver Cancer) 02/2022 - 02/2018
3	Non-alcoholic Fatty Liver Disease 01/2022 - 01/2018
2	Fibrosis (Cirrhosis) 09/2019 - 01/2014
2	Liver Diseases (Liver Disease) 01/2017 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 04/2014 - 02/2012
1	Hypertriglyceridemia 12/2020
1	Bronchiolitis Obliterans Syndrome 09/2019
1	Inflammation (Inflammations) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Fatty Liver 01/2018
1	Alcoholic Fatty Liver 01/2017
1	Type 2 Diabetes Mellitus (MODY) 04/2014
1	Obesity 04/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2014
1	Neoplasm Metastasis (Metastasis) 10/2012
1	Carcinoma (Carcinomatosis) 07/2010

Drug/Important Bio-Agent (IBA)

4	Celecoxib (Celebrex)FDA Link 10/2012 - 12/2009
4	Conjugated Linoleic AcidsIBA 08/2007 - 03/2006
3	Pharmaceutical PreparationsIBA 02/2022 - 12/2009
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2014 - 04/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2014 - 10/2012
3	Biological ProductsIBA 07/2010 - 06/2004
2	Mitogen-Activated Protein Kinase 3IBA 01/2022 - 07/2006
2	InflammasomesIBA 01/2017 - 04/2014
2	ErbB Receptors (EGF Receptor)IBA 04/2014 - 07/2010
2	Epidermal Growth Factor (EGF)IBA 04/2014 - 10/2012
2	Cadherins (E-Cadherin)IBA 10/2012 - 12/2009
2	beta CateninIBA 12/2009 - 08/2007
2	PPAR gammaIBA 08/2007 - 07/2007
2	Phosphotransferases (Kinase)IBA 05/2007 - 06/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2004 - 06/2004
1	Liposomes (Liposome)IBA 02/2022
1	JNK Mitogen-Activated Protein KinasesIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Liver X ReceptorsIBA 12/2020
1	Hypoxia-Inducible Factor 1IBA 12/2019
1	Oncostatin MIBA 12/2019
1	CollagenIBA 09/2019
1	Hyaluronic Acid (Hyaluronan)IBA 09/2019
1	LanthanumIBA 02/2018
1	CeriumIBA 02/2018
1	Amino Acids FDA Link 01/2018
1	Methionine (L-Methionine)FDA Link 01/2018
1	Choline (Choline Chloride)IBA 01/2018
1	histidine-rich proteinsIBA 01/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2017
1	AdipokinesIBA 04/2014
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2014
1	Trypan Blue FDA Link 04/2014
1	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 04/2014
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 02/2014
1	AntigensIBA 02/2014
1	clonidine-displacing substance (ClDS)IBA 01/2014
1	ElementsIBA 01/2014
1	VimentinIBA 10/2012
1	CateninsIBA 10/2012
1	NO-rofeIBA 02/2012
1	rofecoxib (Vioxx)FDA Link 02/2012
1	EnzymesIBA 04/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	NitratesIBA 07/2010
1	Estrogen ReceptorsIBA 07/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2010
1	PPAR alphaIBA 10/2008
1	Arachidonic Acid (Vitamin F)IBA 10/2008
1	LigandsIBA 07/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2007
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 07/2006
1	Estrogens (Estrogen)FDA Link 03/2006
1	parthenolideIBA 10/2004
1	tyrosine receptor (receptor, tyrosine)IBA 06/2004
1	Insulin (Novolin)FDA Link 06/2004
1	costunolideIBA 01/2004
1	LactonesIBA 01/2004
1	SesquiterpenesIBA 01/2004

Therapy/Procedure

1	Therapeutics 02/2022